Company Profiles

driven by the PitchBook Platform

Accera

Accera
2001 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Series E LATEST DEAL TYPE
$84.1M LATEST DEAL AMOUNT
$170M TOTAL AMOUNT RAISED
Description

Operator of a clinical development company intended to heal central nervous system diseases. The company's focus lies in pioneering novel therapeutic approaches to treat neurodegenerative diseases, including Alzheimer's disease, where metabolic dysfunction is a pathophysiological hallmark of the disease.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Primary Office
3005 Center Green Drive
Suite 205
Boulder, CO 80301
United States

+1 (303) 999-3700
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Accera’s full profile, request a free trial.

Accera Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series E) 21-Jan-2014 $84.1M $170M 00000 Completed Generating Revenue
7. Loan 24-May-2012 00.000 000.00 Completed Generating Revenue
6. Later Stage VC (Series C1) 21-Dec-2010 0000 000.00 00000 Completed Generating Revenue
5. Later Stage VC 15-Mar-2010 000.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 12-Nov-2008 0000 000.00 Completed Generating Revenue
3. Bridge 16-Jun-2008 000 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 16-Aug-2006 $7.5M $13.5M $18M Completed Generating Revenue
1. Early Stage VC (Series A) 16-Sep-2004 $6M $6M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding request access »

Accera Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series E 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series C1 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A 12,044,903 $0.001000 $7.64 $7.64 1x $7.64 37.19%
To view this company’s complete Cap Table request access »

Accera Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Innova Capital (Brazil) Venture Capital Minority 000 0000 000000 0
Inventages Venture Capital Venture Capital Minority 000 0000 000000 0
Nestlé Health Science Corporation Minority 000 0000 000000 0
Posco BioVentures Venture Capital Minority 000 0000 000000 0

You’re viewing 4 of 4 investors.

Accera Executive Team (9)

Name Title Board
Seat
Contact
Info
Charles Stacey President & Chief Executive Officer
C. Evan Ballantyne Chief Financial Officer
Jerris Knaisch Vice President, Finance
Ernest Wong Ph.D Vice President of Corporate Development
Bruce Morimoto Ph.D Vice President of Drug Developemnt
You’re viewing 5 of 9 executives. Get the full list »

Accera Board Members (4)

Name Representing Role Since Contact
Info
Claude Nash Ph.D Self Chairman 000 0000
Grégory Behar Nestlé Health Science Board Member 000 0000
Sven Thormahlen Ph.D Self Board Member 000 0000
Wolfgang Reichenberger Inventages Venture Capital Board Member 000 0000

You’re viewing 4 of 4 board members.